Glioblastoma adaptive global innovative learning environment

Recruiting

18 years - 99 years

All

Phase 2

10 participants needed

Brief description of study

This research study aims to evaluate multiple investigational treatments for either newly diagnosed or recurrent brain tumors to determine if any of these study treatment(s) improve overall survival as compared to standard treatments. The investigational drugs that will be used in this research study are temozolomide for newly diagnosed glioblastoma and Lomustine for recurrent glioblastomas.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Glioblastoma
Age: 18 years - 99 years
Gender: All

Updated on 19 Feb 2024. Study ID: 834751

Find a site

Your Information has been sent successfully.

Message sent successfully.

We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.

If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.

Send a message

Enter your contact details to connect with study team

View email

Phone

View phone

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.